Is Organon & Co (NYSE: OGN) Proving The Doubters Wrong?
Organon & Co (OGN) concluded trading on Thursday at a closing price of $9.19, with 5.41 million shares of worth about $49.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -40.98% during that period and on Thursday the price saw a loss of […]
Organon & Co (NYSE: OGN) Not A Good Play Anymore?
Organon & Co (OGN) concluded trading on Thursday at a closing price of $9.54, with 6.85 million shares of worth about $65.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.57% during that period and on May 29, 2025 the price saw a […]
Organon & Co (NYSE: OGN): The Best-Of-Breed For Investing?
Currently, there are 259.96M common shares owned by the public and among those 259.00M shares have been available to trade. The company’s stock has a 5-day price change of 3.79% and -42.71% over the past three months. OGN shares are trading -41.29% year to date (YTD), with the 12-month market performance down to -59.29% lower. […]
Organon & Co (NYSE: OGN) Is Getting Increasingly Hard To Ignore
Currently, there are 259.96M common shares owned by the public and among those 259.02M shares have been available to trade. The company’s stock has a 5-day price change of -7.56% and -43.55% over the past three months. OGN shares are trading -43.43% year to date (YTD), with the 12-month market performance down to -58.85% lower. […]
Organon & Co (NYSE: OGN) Hogging The Spotlight Today
Currently, there are 259.96M common shares owned by the public and among those 259.08M shares have been available to trade. The company’s stock has a 5-day price change of -21.39% and -38.37% over the past three months. OGN shares are trading -35.72% year to date (YTD), with the 12-month market performance down to -48.47% lower. […]
Organon & Co (OGN) Volatility Spurs A Quest For Clarity
Currently, there are 257.80M common shares owned by the public and among those 257.08M shares have been available to trade. The company’s stock has a 5-day price change of 17.08% and -18.06% over the past three months. OGN shares are trading -11.80% year to date (YTD), with the 12-month market performance down to -28.56% lower. […]
Organon & Co (NYSE: OGN) Hogging The Spotlight Today
Currently, there are 257.80M common shares owned by the public and among those 257.08M shares have been available to trade. The company’s stock has a 5-day price change of -0.53% and -29.22% over the past three months. OGN shares are trading -24.66% year to date (YTD), with the 12-month market performance down to -37.07% lower. […]
Analysts Update Their Price Forecasts For Organon & Co. (OGN)
Organon & Co. (OGN) concluded trading on Wednesday at a closing price of $16.36, with 3.56 million shares of worth about $58.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -29.66% during that period and on Wednesday the price saw a gain of […]
Organon & Co. (NYSE: OGN): Stock That Needs Special Handling
The Vanguard Group, Inc. recently announced the acquisition of new stake in Organon & Co. (NYSE:OGN). The institutional investor has increased its shareholding in the Healthcare company by 0.08% to 30.53 million shares with purchase of 24860.0 shares. This fresh investment now brings its stake to 11.94% valued currently at $345.55 million. In addition, SSgA […]
An Important Check-Up On Organon & Co. (NYSE: OGN)
The Vanguard Group, Inc. has recently announced that it has increased stake in Organon & Co. (NYSE:OGN) by 0.08%. After grabbing 30.53 million shares, the institutional investor is now in possession of 24860.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 11.94% having worth around $345.55 million. Moreover, […]